About Us | Get a Quote | Contact Us
Combination Therapy Cancer Treatment in India Hospitals
Call Now At:+91­9029304141 +1(408)­465 5252  10AM To 8PM
( only for international patients seeking treatment in India )
Email : info@wecareindia.com (preferred)
Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals
Combination Therapy Cancer Treatment in India Hospitals
Combination Therapy Cancer Treatment in India Hospitals

Patient Story
Successful Cancer surgery at We Care India partner hospital allows Henry Stolz to live a normal life despite a microendoscopic Decompression. We Care india helped Henry find best super specialised surgeon for his Condition.
Read : Robert's Story
See All : Success Stories

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals




Combination Therapy
Combination therapy may benefit patients with specific genetic subtype of non-small cell lung cancer, study finds

Even when their tumors are shrinking in response to therapy, some non-small cell lung cancer (NSCLC) patients have a scattering of cancer cells that are undeterred by the drug, causing the tumor to resume its growth, Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) Cancer Center scientists report in the January issue of Cancer Cell.
The findings suggest that identifying such patients and treating them with a combination of drugs from the very start of therapy can produce longer remissions.

One of the triggers for resistance, the researchers found, is HGF, a ligand or "hook" that activates the MET protein.

Looking for a free cost estimate for cancer treatment abroad – click here

When activated, HGF works through two entirely different channels to produce drug resistance, the authors report. First, it can generate cell-growth signals through a protein called GAB1. Second, it expands the number of MET-amplified cancer cells, ensuring they will become the dominant type in the lung tumors.

"Not only can HGF spur cell growth on its own, it can speed up the process by which MET-amplified cells emerge and take over the composition of the tumor.

In about 20 percent of NSCLC patients who are resistant to Tarceva the mechanism is amplification of MET, and in another 20 percent it may involve HGF.

The findings suggest that patients whose NSCLC tumors harbor even a few MET-amplified cells prior to treatment would benefit from drugs that specifically target those cells, in combination with a tyrosine kinase inhibitor. Jänne notes that such drugs are already being studied in clinical trials.

Get an expert medical opinion – click here

A thorough analysis of a patient's cancer prior to treatment can establish how it would ultimately develop resistance to therapy, allowing us to tailor treatment with greater precision to prevent resistance.

"For example, cancers found to harbor a small population of cells with pre-existing MET amplification will likely benefit from adding MET inhibitors to initial treatment. Those without such cells may not benefit, and these patients can avoid the added toxicity of MET inhibitors and instead focus on other strategies to prevent their cancers from becoming resistant."

Do you have your medical reports, send us now for a free quote –
click here
For more information, medical assessment and medical quote
send your detailed medical history and medical reports
as email attachment to
Call: +91 9029304141 (10 am. To 8 pm. IST)
(Only for international patients seeking treatment in India)
Top
Worried for treatment, take a free second opinion – click here

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Gender :
  

(We Keep your information 100% Secure and Private)


For a detailed evaluation send patient’s medical reports / X rays / doctors notes to info@wecareindia.com

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India HospitalsMedical Tourism Guide

Combination Therapy Cancer Treatment in India HospitalsCancer Treatment Guide

Combination Therapy Cancer Treatment in India Hospitals
Follow Us:
Combination Therapy Cancer Treatment in India Hospitals
Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals

Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals
 

© 2013 We Care Health Services. All rights reserved.

This information is not designed to replace a physician's independent judgment about the appropriateness or risks of a procedure for a given patient.
Always consult your doctor about your medical condition. We Care Health Services does not provide medical advice, diagnosis or treatment. Use of the cancertreatment-wecareindia.com site is conditional upon your acceptance of our Terms and Conditions

cancertreatment-wecareindia is a member of wecareindia.com Combination Therapy Cancer Treatment in India Hospitals medical tourism information network
 
Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals Combination Therapy Cancer Treatment in India Hospitals